Contribution of head-up tilt testing and ATP testing in assessing the mechanisms of vasovagal syndrome: Preliminary results and potential therapeutic implications

Circulation

Volumn 99, Issue 18, 1999, Pages 2427-2433

  Flammang, Daniel ^a   Erickson, Mark ^b   McCarville, Sally ^b   Church, Timothy ^c   Hamani, Djamel ^a   Donal, Erwan ^a  

^a Angouleme General Hospital   (France)

^b MEDTRONIC INC   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Adenosine; Syncope; Tests; Vagus nerve

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; DAILY LIFE ACTIVITY; FEMALE; HEAD TILTING; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PRIORITY JOURNAL; RISK ASSESSMENT; SYMPATHETIC TONE; SYNCOPE; TASK PERFORMANCE; VAGUS NERVE;

EID: 0033545964     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.18.2427     Document Type: Article

References (42)

1. Kapoor WN, Hammill SC, Gersh BJ. Diagnosis and natural history of syncope and the role of invasive electrophysiologic testing. Am J Cardiol. 1989;63:730-734.
2. Benditt DG. Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation. Pacing Clin Electrophysiol. 1997;20: 572-584.
3. Kenny RA, Bayliss J, Ingram A, Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet. 1986;1:1354-1358.
4. Grubb BP, Kosinski D. Tilt table testing: concepts and limitations. Pacing Clin Electrophysiol. 1997;20:781-787.
5. Flammang D, Church T, Waynberger M, Chassing A, Antiel M. Can adenosine-5′-triphosphate be used to select treatment in severe vasovagal syndrome? Circulation. 1997;26:1201-1208.
6. Fitzpatrick A, Theodorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol. 1991;17:125-130.
7. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med. 1994;97:78-88.
8. Benditt DG, Remole S, Bailin S, Dunnigan A, Asso A, Milstein S. Tilt table testing for evaluation of neurally mediated (cardio-neurogenic) syncope: rationale and proposed protocols. Pacing Clin Electrophysiol. 1994;11:1528-1537.
9. Kapoor WN, Brant N. Evaluation of syncope by upright tilt testing with isoproterenol: a nonspecific test. Ann Intern Med. 1992;116:358-363.
10. Hughes FC, Jan Y, Bors V, Baubion N. Etude de l'action chronotrope de l'ATP chez l'homme. Coeur Med Intern. 1980;19:227-234.
11. Puech P, Sassine A, Munoz A, Masse C, Zettelmaier F, Leenhardt A, Yoshimura H. Electrophysiologic effects of purine: clinical applications. In: Zipes D, Jalife J, eds. Cardiac Electrophysiology and Arrhythmias. Orlando, Fla: Grune & Stratton; 1985:443-450.
12. Mehta C, Patel N. StatXact-Turbo User Manual. Cambridge, Mass: Cytel Corp; 1992;4:68-69.
13. SYSTAT for Windows: Statistics: Version 5. Evanston, Ill: SYSTAT Inc; 1992.
14. S-Plus 4 Guide to Statistics. Seattle, Wash: Data Analysis Products Division, MathSoft; 1997.
15. Oribe E, Caro S, Perera R, Winters SL, Gomes A, Kaufmann H. Syncope: the diagnostic value of head-up tilt testing. Pacing Clin Electrophysiol. 1997;20(pt I):874-879.
16. Moya A, Sagrista J, Permanyer-Miralda G, Romero B. Isoproterenol and tilt test: protocol, importance, contraindications. In: Blanc JJ, Benditt D, Sutton R, eds. Neurally Mediated Syncope: Physiopathology, Investigations, and Treatment. Armonk, NY: Futura Publishing; 1996:85-90.
17. Grubb BP, Wolfe D, Temesy-Armos P, Hahn H, Elliott L. Reproducibility of head-up tilt table test: results in patients with syncope. Pacing Clin Electrophysiol. 1992;15:1477-1481.
18. Sutton R, Petersen M. The clinical spectrum of neurocardiogenic syncope. J Cardiovasc Electrophysiol. 1995;6:569-576.
19. Calkins H, Kadish A, Sousa J, Rosenheck S, Morady F. Comparison of responses to isoproterenol and epinephrine during head-up tilt in suspected vasodepressor syncope. Am J Cardiol. 1991;67:207-209.
20. Lurie KG, Dutton J, Mangat R, Newman D, Eisenberg S, Scheinman M. Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt table testing. Am J Cardiol. 1993;72:1286-1290.
21. Raviele M, Menozzi C, Brignole M, Gasparini G, Alboni P, Musso G, Lolli G, Oddone D, Dinelli M, Mureddu R. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol. 1995;76:267-272.
22. Pelleg A, Hurt CM. Mechanism of action of ATP on canine pulmonary vagal C fibre nerve terminals. J Physiol. 1996;490:265-275.
23. Armour JA, Huang MH, Pelleg A, Sylvén C. Responsiveness of in situ canine nodose ganglion afferent neurons to epicardial mechanical or chemical stimuli. Cardiovasc Res. 1994;28:1218-1225.
24. Hurt CM, Wang L, Xu J, Sterious W, Pelleg A. Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in dogs, II: vagal afferent traffic. Am J Physiol. 1994;267:H1093-H1097.
25. Pelleg A, Belhassen B, Ilia R, Laniado S. Comparative electrophysiologic effects of adenosine triphosphate and adenosine in the canine heart: influence of atropine, propranolol, vagotomy, dipyridamole and aminophylline. Am J Cardiol. 1985;55:571-576.
26. Munoz A, Sassine A, Lehujeur C, Koliopoulos N, Puech P. Mode d'action des substances purinergiques dérivées de l'adénine sur la conduction auriculo-ventriculaire: etude expérimentale chez le chien. Arch Mal Coeur. 1985;78:143-150.
27. Belhassen B, Ilia R, Pelleg A, Greenspan A, Horowitz L. A comparative study of the electrophysiologic effects of striadyne, adenosine triphosphate and adenosine in the canine heart. Cardiology. 1985;72: 113-122.
28. Pelleg A, Belardinelli. Cardiac electrophysiology and pharmacology of adenosine: basic and clinical aspects. Cardiovasc Res. 1993;27:54-61.
29. Katchanov G, Xu J, Clay A, Pelleg A. Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in dogs, IV: role of LV vagal afferents. Am J Physiol. 1997;272(Heart Circ Physiol 41): H1898-H1903.
30. Sharma AD, Rinne E, Klein GJ, Yee R, Szabo T. Negative chronotropic effects of adenosine triphosphate on the sinus node are mediated by muscarinic cholinergic and not purinergic receptors. J Am Coll Cardiol. 1988;11:227A. Abstract.
31. Brignole M, Gaggioli G, Menozzi C, Gianfranchi L, Bartoletti A, Bottoni N, Lolli G, Oddone D, Del Rosso A, Pellinghelli G. Adenosine-induced atrioventricular block in patients with unexplained syncope: the diagnostic value of ATP testing. Circulation. 1997;96:3921-3927.
32. Fitzpatrick AP, Ahmed R, Williams S, Sutton R. A randomized trial of medical therapy in malignant vasovagal syndrome or neurally mediated bradycardia/hypotension syndrome. Eur J Card Pacing Electrophysiol. 1991;1:99-102.
33. Recommendations for pacemaker prescription for symptomatic bradycardia: a report of a working party of the British Pacing and Electrophysiology Group. Br Heart J. 1991;66:185-191.
34. Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J. 1994;71:274-281.
35. Sra JS, Akhtar M. Cardiac pacing during neurocardiogenic (vasovagal) syncope. J Cardiovasc Electrophysiol. 1995;6:751-760.
36. Natale A, Sra J, Dhala A, Wase A, Jazayeri M, Deshpande S, Blanck Z, Akhtar M. Efficacy of different treatment strategies for neurocardiogenic syncope. Pacing Clin Electrophysiol. 1995;18(pt I):655-662.
37. Fitzpatrick AP, Theodorakis G, Ahmed R, Williams T, Sutton R. Dual chamber pacing aborts vasovagal syncope induced by head-up 60° tilt. Pacing Clin Electrophysiol. 1991;14:13-19.
38. Sra JS, Jazayeri MR, Avitall B, Dhala A, Deshpande S, Blanck Z, Akhtar M. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med. 1993;328:1085-1090.
39. Petersen MEV, Price D, Williams T, Jensen N, Rift K, Sutton R. Short AV delay VDD pacing does not prevent tilt induced vasovagal syncope in patients with cardio-inhibitory vasovagal syndrome. Pacing Clin Electrophysiol. 1994;17:882-891.
40. El-Bedawi, Wahbha MMAE, Hainsworth R. Cardiac pacing does not improve orthostatic tolerance in patients with vasovagal syncope. Clin Auton Res. 1995;4:233-237.
41. Petersen M, Sutton R. Cardiac pacing for vasovagal syncope: a reasonable therapeutic option? Pacing Clin Electrophysiol. 1997;20(pt II): 824-826.
42. Benditt D, Sutton R, Gammage M, Markowitz T, Gorski J, Nygaard G, Fetter J, and the International Rate-Drop Investigators Group. Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. Pacing Clin Electrophysiol. 1997;20(pt II):832-839.